HRP20151311T1 - Kontrolirana aktivacija mehanizma proizvodnje reuterina stanica lactobacillus reuteri - Google Patents
Kontrolirana aktivacija mehanizma proizvodnje reuterina stanica lactobacillus reuteri Download PDFInfo
- Publication number
- HRP20151311T1 HRP20151311T1 HRP20151311TT HRP20151311T HRP20151311T1 HR P20151311 T1 HRP20151311 T1 HR P20151311T1 HR P20151311T T HRP20151311T T HR P20151311TT HR P20151311 T HRP20151311 T HR P20151311T HR P20151311 T1 HRP20151311 T1 HR P20151311T1
- Authority
- HR
- Croatia
- Prior art keywords
- lactobacillus reuteri
- fermentation
- cells
- cell cultures
- reuterin
- Prior art date
Links
- 241000186604 Lactobacillus reuteri Species 0.000 title claims 10
- 229940001882 lactobacillus reuteri Drugs 0.000 title claims 10
- 238000004519 manufacturing process Methods 0.000 title claims 7
- 230000004913 activation Effects 0.000 title 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 15
- 238000000855 fermentation Methods 0.000 claims 9
- 230000004151 fermentation Effects 0.000 claims 9
- 238000004113 cell culture Methods 0.000 claims 8
- 238000000034 method Methods 0.000 claims 6
- AKXKFZDCRYJKTF-UHFFFAOYSA-N 3-Hydroxypropionaldehyde Chemical compound OCCC=O AKXKFZDCRYJKTF-UHFFFAOYSA-N 0.000 claims 4
- 238000004108 freeze drying Methods 0.000 claims 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 229930003268 Vitamin C Natural products 0.000 claims 1
- 239000010941 cobalt Substances 0.000 claims 1
- 229910017052 cobalt Inorganic materials 0.000 claims 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 1
- 239000002577 cryoprotective agent Substances 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 1
- 244000052769 pathogen Species 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- 235000013772 propylene glycol Nutrition 0.000 claims 1
- 235000019154 vitamin C Nutrition 0.000 claims 1
- 239000011718 vitamin C Substances 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/32—Processes using, or culture media containing, lower alkanols, i.e. C1 to C6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Claims (9)
1. Metoda proizvodnje stanica Lactobacillus reuteri koje imaju sačuvan reuterin unutar stanica, koja sadrži:
proizvodnju staničnih kultura Lactobacillus reuteri, gdje proizvodnja sadrži fermentiranje navedenih staničnih kultura;
dodavanje 1,2-propandiola ili glicerola staničnim kulturama Lactobacillus reuteri na početku fermentacije, pripremajući na taj način mehanizam proizvodnje reuterina kod stanica Lactobacillus reuteri;
dodavanje glicerola staničnim kulturama Lactobacillus reuteri u tijeku proizvodnje, osiguravajući na taj način da stanice Lactobacillus reuteri imaju sačuvan reuterin u stanicama; i
konzerviranje stanica Lactobacillus reuteri pomoću liofilizacije staničnih kultura nakon fermentacije.
2. Metoda prema patentnom zahtjevu 1, naznačena time da fermentacija sadržava dodavanje glicerola na kraju postupka fermentacije.
3. Metoda prema patentnom zahtjevu 1, naznačena time da nadalje sadrži dodavanje barem jednog krioprotektora zajedno s glicerolom staničnoj kulturi u koraku fermentacije, prije liofilizacije.
4. Metoda prema patentnom zahtjevu 1, naznačena time da je oko 1 do oko 500 mM glicerola dodano u proizvodnom procesu nakon koraka fermentacije ali prije liofilizacije.
5. Metoda prema bilo kojem patentnom zahtjevu 2-4, naznačena time da fermentacija staničnih kultura Lactobacillus reuteri nadalje sadrži pripremanje staničnih kultura s barem jednim od kobalta, vitamina B-12, vitamina C, ili njihovim kombinacijama na početku koraka fermentacije.
6. Proizvod dobiven metodom prema bilo kojem patentnom zahtjevu 1-5, naznačen time da sadrži liofilizirane stanice Lactobacillus reuteri koje imaju sačuvan reuterin unutar stanica.
7. Proizvod prema patentnom zahtjevu 6, naznačen time da je za liječenje životinja uključujući ljude.
8. Proizvod prema patentnom zahtjevu 6, naznačen time da je za upotrebu u liječenju poremećaja uzrokovanih patogenima kožnog sustava.
9. Farmaceutski sastav koji sadrži proizvod prema patentom zahtjevu 6.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13160808P | 2008-06-10 | 2008-06-10 | |
US12/481,530 US8617537B2 (en) | 2008-06-10 | 2009-06-09 | Controlled activation of the reuterin-production machinery of lactobacillus |
EP09762760.8A EP2303295B1 (en) | 2008-06-10 | 2009-06-10 | Controlled activation of the reuterin-production machinery of lactobacillus reuteri |
PCT/SE2009/050707 WO2009151391A1 (en) | 2008-06-10 | 2009-06-10 | Controlled activation of the reuterin-production machinery of lactobacillus reuteri |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20151311T1 true HRP20151311T1 (hr) | 2016-01-01 |
Family
ID=41400511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20151311TT HRP20151311T1 (hr) | 2008-06-10 | 2015-12-01 | Kontrolirana aktivacija mehanizma proizvodnje reuterina stanica lactobacillus reuteri |
Country Status (13)
Country | Link |
---|---|
US (3) | US8617537B2 (hr) |
EP (1) | EP2303295B1 (hr) |
JP (2) | JP5620371B2 (hr) |
KR (1) | KR101700967B1 (hr) |
CN (1) | CN102026644B (hr) |
AU (1) | AU2009258303B2 (hr) |
DK (1) | DK2303295T3 (hr) |
HR (1) | HRP20151311T1 (hr) |
HU (1) | HUE026786T2 (hr) |
RU (1) | RU2492870C2 (hr) |
SI (1) | SI2303295T1 (hr) |
UA (1) | UA100423C2 (hr) |
WO (1) | WO2009151391A1 (hr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112013020695A2 (pt) * | 2011-02-23 | 2016-10-25 | Biogaia Ab | substratos indiretos para os microorganismos que metabolizam 1,2 - propanodiol |
JP2014506923A (ja) | 2011-03-01 | 2014-03-20 | クオラム イノベーションズ リミテッド ライアビリティ カンパニー | 病原性バイオフィルムと関連した状態を治療するための物質および方法 |
EP2674162A1 (en) * | 2012-05-29 | 2013-12-18 | Danuta Kruszewska | Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same |
CZ306548B6 (cs) * | 2014-12-04 | 2017-03-01 | Výzkumný ústav mlékárenský, s.r.o. | Probiotický přípravek sušený se zvlhčujícím efektem pro speciální aplikace |
HUE062482T2 (hu) * | 2015-01-14 | 2023-11-28 | Infant Bacterial Therapeutics Ab | Lactobacillus reuteri- és citráttartalmú készítmény gyógyászati felhasználásra |
CN105851063B (zh) * | 2016-04-29 | 2018-07-24 | 浙江工商大学 | 一种罗伊氏素手机抑菌喷雾的生产方法 |
JPWO2017217350A1 (ja) | 2016-06-13 | 2019-02-21 | 株式会社村田製作所 | 抗菌抗ウイルス薬、抗菌抗ウイルス部材、及び抗菌抗ウイルス薬の製造方法 |
WO2018083336A1 (en) * | 2016-11-07 | 2018-05-11 | Biogaia Ab | Activated lactobacillus reuteri strains for selective pathogen inhibition in a human microbial community |
CN107739747B (zh) * | 2017-09-27 | 2020-06-02 | 浙江工商大学 | 一种利用罗伊氏乳杆菌与醋杆菌共发酵高密度生产罗伊特林素的方法 |
US11213055B2 (en) | 2017-12-28 | 2022-01-04 | Third Wave Bioactives, Llc | Fermentate compositions and methods of making and using the same |
KR102122652B1 (ko) * | 2018-09-07 | 2020-06-12 | 건국대학교 산학협력단 | 락토바실러스 루테리 제제를 이용한 피부개선용 조성물 |
CN109182397B (zh) * | 2018-09-18 | 2022-05-24 | 北京大伟嘉生物技术股份有限公司 | 一种提高罗伊氏菌素产量的方法 |
CN109628359B (zh) * | 2019-02-22 | 2021-03-02 | 江南大学 | 一株可缓解过敏性哮喘的罗伊氏乳杆菌及其应用 |
CN109868246B (zh) * | 2019-04-03 | 2021-11-23 | 吉林大学 | 一种林蛙油酶解液对罗伊氏乳杆菌冻干保护的方法 |
KR102510953B1 (ko) * | 2020-11-24 | 2023-03-16 | 연세대학교 산학협력단 | 알러지성 질환의 예방 또는 치료용 조성물 |
KR102588346B1 (ko) * | 2020-11-27 | 2023-10-11 | 코오롱인더스트리(주) | 신규 락토바실러스 루테리 균주 및 이의 용도 |
CN112553117B (zh) * | 2020-12-24 | 2022-04-29 | 江南大学 | 一株能够抑制皮肤角质层增厚的罗伊氏乳杆菌及其应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US201996A (en) | 1878-04-02 | Improvement in stop-cocks and boxes for water-pipes | ||
US5413960A (en) * | 1987-05-01 | 1995-05-09 | Biogaia Ab | Antibiotic reuterin |
JP3007092B2 (ja) * | 1987-05-01 | 2000-02-07 | バイオガイア・バイオロジクス・エイビー | 抗生物質レウテリン |
US5352586A (en) * | 1987-05-01 | 1994-10-04 | Biogaia Ab | Method of determining the presence of an antibiotic produced by Lactobacillus reuteri |
US5458875A (en) * | 1990-06-15 | 1995-10-17 | Biogaia Ab | In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry |
US5534253A (en) * | 1995-06-07 | 1996-07-09 | Biogaia Ab | Method of treating enteropathogenic bacterial infections in poultry |
US5837238A (en) * | 1996-06-05 | 1998-11-17 | Biogaia Biologics Ab | Treatment of diarrhea |
ES2255730T3 (es) | 1997-04-18 | 2006-07-01 | Ganeden Biotech, Inc. | Utilizacion topica de esporas de bacilos probioticos para prevenir o tratar las infecciones microbianas. |
DK173239B1 (da) * | 1998-06-25 | 2000-05-22 | Danske Slagterier | Fremgangsmåde og middel til desinficering af udstyr i levnedsmiddelvirksomheder, fortrinsvis udstyr, der anvendes ved slagt |
US20050220777A1 (en) * | 2003-11-21 | 2005-10-06 | Stefan Roos | Selection of lactic acid bacteria enhancing the immune response against Streptococcus pneumoniae |
-
2009
- 2009-06-09 US US12/481,530 patent/US8617537B2/en not_active Expired - Fee Related
- 2009-06-10 DK DK09762760.8T patent/DK2303295T3/en active
- 2009-06-10 AU AU2009258303A patent/AU2009258303B2/en not_active Ceased
- 2009-06-10 SI SI200931332T patent/SI2303295T1/sl unknown
- 2009-06-10 JP JP2011513457A patent/JP5620371B2/ja not_active Expired - Fee Related
- 2009-06-10 WO PCT/SE2009/050707 patent/WO2009151391A1/en active Application Filing
- 2009-06-10 RU RU2010153999/15A patent/RU2492870C2/ru active
- 2009-06-10 KR KR1020107028943A patent/KR101700967B1/ko active IP Right Grant
- 2009-06-10 HU HUE09762760A patent/HUE026786T2/en unknown
- 2009-06-10 CN CN2009801176465A patent/CN102026644B/zh not_active Expired - Fee Related
- 2009-06-10 EP EP09762760.8A patent/EP2303295B1/en not_active Not-in-force
- 2009-10-06 UA UAA201015969A patent/UA100423C2/uk unknown
-
2013
- 2013-11-04 US US14/070,814 patent/US8945534B2/en not_active Expired - Fee Related
-
2014
- 2014-07-24 JP JP2014150525A patent/JP2014230541A/ja not_active Abandoned
- 2014-12-19 US US14/577,122 patent/US20150104852A1/en not_active Abandoned
-
2015
- 2015-12-01 HR HRP20151311TT patent/HRP20151311T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
EP2303295A1 (en) | 2011-04-06 |
RU2010153999A (ru) | 2012-07-20 |
CN102026644A (zh) | 2011-04-20 |
JP2011522885A (ja) | 2011-08-04 |
US8617537B2 (en) | 2013-12-31 |
CN102026644B (zh) | 2012-12-05 |
HUE026786T2 (en) | 2016-08-29 |
US8945534B2 (en) | 2015-02-03 |
WO2009151391A1 (en) | 2009-12-17 |
US20140057992A1 (en) | 2014-02-27 |
US20090304656A1 (en) | 2009-12-10 |
EP2303295A4 (en) | 2012-01-11 |
SI2303295T1 (sl) | 2016-01-29 |
KR101700967B1 (ko) | 2017-01-31 |
JP5620371B2 (ja) | 2014-11-05 |
RU2492870C2 (ru) | 2013-09-20 |
AU2009258303A1 (en) | 2009-12-17 |
JP2014230541A (ja) | 2014-12-11 |
EP2303295B1 (en) | 2015-09-30 |
AU2009258303A2 (en) | 2010-12-16 |
KR20110015640A (ko) | 2011-02-16 |
UA100423C2 (uk) | 2012-12-25 |
US20150104852A1 (en) | 2015-04-16 |
DK2303295T3 (en) | 2016-01-04 |
AU2009258303B2 (en) | 2014-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20151311T1 (hr) | Kontrolirana aktivacija mehanizma proizvodnje reuterina stanica lactobacillus reuteri | |
PH12015502860A1 (en) | A method of freeze-drying encapsulated cells, freeze-dried encapsulated cells, compositions containing freeze-dried encapsulated cells and uses of such cells and compositions | |
PH12015500633A1 (en) | Method for preparing imp fermented broth or glutamic acid fermented broth as raw material for preparation of natural flavor | |
BRPI0518101A (pt) | métodos de produção e sìntese de composições nanoparticuladas, composições obtidas e seu uso | |
BR112015009975A2 (pt) | métodos e composições para a estimulação das bactérias benéficas no trato gastrointestinal | |
CL2012002013A1 (es) | Microorganismos aislado thrastochytrium sp. atcc pta-10212 util en la produccion de acidos grasos omega-3 | |
CL2015003188A1 (es) | Divisional de la solicitud 578-2014 por composición controladora de enfermedades en plantas y métodos para controlar enfermedades en plantas | |
JP2016531131A5 (hr) | ||
BR112014008700A2 (pt) | composições úteis no tratamento de nefropatia e processos para preparação das mesmas | |
BR112018068473A2 (pt) | meio de formação de colônias e uso das mesmas | |
HN2011001195A (es) | Compuestos que expanden las celulas madre hematopoieticas | |
CO6150099A2 (es) | Agente de mejoramiento de fermentacion del rumen | |
WO2013100818A3 (en) | A biocomposite for regeneration of injured tissue and organs, a kit for making the biocomposite, a method of making the biocomposite and a method of treating inquiries. | |
HRP20200038T1 (hr) | Poboljšani pripravci hetero- i homofermentativnih mliječnih kiselina bakterijskih vrsta za dvojnu namjenu održavanja silaže | |
BR112018075548A2 (pt) | método para estabilizar proteínas | |
AR080816A1 (es) | Preparacion derivada de un cultivo in vitro de celulas de argan no evocadas desdiferenciadas, su uso para el tratamiento del envejecimiento, la inflamacion y curacion de la piel, y metodo para su obtencion | |
MX2017012124A (es) | Esencia del extracto de tien-cha y aplicacion de la misma. | |
JP2013520271A5 (hr) | ||
MY196026A (en) | Stem Cell Conditioned Media for Clinical and Cosmetic Applications | |
BR112012015449A2 (pt) | suspensão de monoidrato de calcipotriol, monoidrato de calcipotriol, processo para preparar nanocristais de monoidrato de calcipotriol, e, composição farmacêutica | |
AR074406A1 (es) | Celulas madre terapeuticas derivadas de monocitos humanos y un metodo para inducir celulas madre terapeuticas derivadas de monocitos humanos | |
BR112014004123A2 (pt) | micro-organismos das espécies bacteroides xylanisolvens | |
AR085655A1 (es) | Extracto de cinnamomum burmanii, proceso de extraccion y su uso como regulador por disminucion de la bomba de protones, inhibidor enzimatico, y mucoprotector | |
MX2023005014A (es) | Metodos de tratamiento de enfermedades inflamatorias cronicas. | |
AR110634A1 (es) | Método para preparar un suplemento a partir de cultivos de células mesenquimales de gelatina de wharton y usos del mismo |